XMXiang Meng

Xiang Meng

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Xiang Meng has a total of 31 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Willingness to Receive Maternal RSV Vaccination Among Pregnant Women and Those Planning Pregnancy in Southern China: A Cross-Sectional Study and Predictive Nomogram

    by Xiang Meng, Sijie Li, Meiyan Li, Cheng Guo, Ping Wang, Xuejuan Chen, Dingmei Zhang, Yonghui Zhong

    Background/Objectives: Maternal immunization against respiratory syncytial virus (RSV) is an emerging strategy to protect infants during early life when they are most vulnerable to severe RSV infection. However, little is known about the willingness to receive maternal RSV vaccination in China, where the vaccine has not yet been officially approved for marketing. This study aimed to assess the willingness to receive maternal RSV vaccination among women who are currently pregnant and those planning pregnancy in Guangzhou, and to identify the key determinants influencing vaccination willingness. Methods: A cross-sectional survey was conducted in April 2025 among 406 women at Guangzhou Women and Children’s Medical Center, China. Participants completed a self-administered questionnaire covering predisposing factors, enabling resources, health behaviors and awareness, and need factors. Logistic regression analyses were used to identify factors associated with vaccine willingness. A nomogram prediction model was constructed based on significant predictors. Results: Overall, 67.2% (n = 273) of participants reported willingness to receive maternal RSV vaccination. Younger maternal age, higher levels of social support, moderate or high perceived RSV risk, a history of HPV vaccination, and having medical insurance were independently associated with higher willingness to vaccinate. A predictive nomogram incorporating these factors demonstrated good discrimination (AUC = 0.753) and calibration. Age-stratified analysis revealed differing concerns across age groups, with vaccine safety and neonatal protection being the most cited factors influencing decision-making. Conclusions: This study provides the first evidence on maternal RSV vaccination willingness in southern China and highlights several psychosocial and demographic factors influencing vaccine intentions. The nomogram offers a practical tool to estimate individual willingness and guide targeted communication. These findings have implications for future maternal RSV vaccine application strategies in China.


  • Open Access

    Characteristics and economic burden of hospitalized tuberculosis patients in Guangdong Province, China, from 2017 to 2023: a population-based study

    by Sijie Li, Yunlian Xue, Xiang Meng, Guihao Liu, Shasha Yuan, Liang Chen, Xiaowan Wang, Dingmei Zhang, Lin Zhou

    Tuberculosis, caused by Mycobacterium tuberculosis, remains a leading global health issue, especially in developing countries. In China, tuberculosis preve


  • Open Access

    Determinants and nomogram prediction of catastrophic health expenditures on respiratory diseases and tuberculosis in Guangdong Province—based on National Health Services Surveys in China (Preprint)

    by Xiang Meng, Yunlian Xue, Sijie Li, Guihao Liu, Shasha Yuan, Liang Chen, Xiaowan Wang, Xiangyong Li, Lin Zhou

    BACKGROUND Catastrophic health expenditures (CHE) severely impact families, especially in the context of respiratory diseases and tuberculosis. This study evaluates the determinants of CHE and construct nomogram prediction, with a focus on the diverse impacts of regional disparities and income levels in Guangdong Province, China, drawing from the National Health Services Surveys (NHSS) conducted in 2013 and 2023. OBJECTIVE To evaluate the determinants of catastrophic health expenditures (CHE) among individuals with respiratory diseases and tuberculosis in Guangdong Province, China, using data from the 2013 and 2023 National Health Services Surveys, and to develop and validate nomograms for predicting CHE while assessing the roles of regional disparities, income levels, and other socioeconomic factors. METHODS This multi-year, cross-sectional study utilized data from two NHSS in Guangdong Province. The study population consists of individuals aged 15 years and above with respiratory diseases or tuberculosis in Guangdong Province. CHE was defined as medical and health expenditures exceeding 40% of non-food household expenditures. We employed stepwise logistic regression analyses to identify the determinants of CHE and developed nomograms for prediction, with the Receiver operating characteristic (ROC) curves and the area under the curve (AUC), calibration plots, and decision curve analysis (DCA) utilized to evaluate the predictive accuracy and practical applicability of the models. Mediation analysis was conducted to assess the roles of income and age between regional disparities and the occurrence of CHE. RESULTS The incidence of CHE was relatively stable in 2013 (13.5%) and 2023 (13.6%). Significant risk factors included increasing age [OR: 2.615 (1.681, 4.069)], having other chronic diseases [OR: 1.921 (1.177, 3.133)], living in northern Guangdong region [OR: 2.043 (1.204, 6.466)], and insomnia almost every day [OR: 2.843 (1.345, 6.013)], while protective factors included higher income [OR: 0.204 (0.046, 0.918)], being widowed and divorce [OR: 0.120 (0.035, 0.415)] and so on. The mediation analysis highlighted income as a crucial mediator between region and CHE occurrence. Nomograms showed good predictive ability with areas under the curve (AUCs) ranging from 0.844 to 0.884 for training datasets across different survey years and the decision curve analysis (DCA) showing excellent clinical benefits. CONCLUSIONS The study highlights the significant effect of regional disparities and socioeconomic status on CHE in Guangdong Province. Income played a pivotal role in mediating these effects, emphasizing the need for targeted economic policies to reduce the burden of health expenditures. The developed nomograms offer practical tools for predicting CHE, aiding healthcare providers in resource allocation and decision-making.

  • Open Access

    Have Previous COVID-19 Vaccinations Shaped the Potential Enhancing Infection of Variant Strains?

    by Husheng Xiong, Xiang Meng, Yanqin Song, Jiayi Zhong, Shuang Liu, Xun Zhu, Xin Ye, Yonghui Zhong, Dingmei Zhang

    Objective: This study aimed to investigate the infection status of Omicron in the population and the association between COVID-19 vaccination and infection with Omicron. Methods: We conducted a cross-sectional study to openly recruit participants for a survey of SARS-CoV-2 infection by convenience sampling from 1 January to 15 January 2023 after a COVID-19 pandemic swept across China. Additionally, the binary logistic regression model was adopted to evaluate the association between COVID-19 vaccination and the infection outcomes or symptom severity, respectively. Meanwhile, the relations between the vaccination and duration of the symptoms were estimated via ordinal logistic analysis. Results: Of the 2007 participants, the prevalence of infection with Omicron was 82.9%. Compared with unvaccinated individuals, inactivated COVID-19 vaccination could increase the risk of Omicron infection (OR = 1.942, 95% CI: 1.093–3.448), and the receipt of at least one dose of non-inactivated COVID-19 vaccines was a protective factor against infection (OR = 0.428, 95% CI: 0.226–0.812). By contrast, no relations were observed in COVID-19 vaccination with the symptoms of infection and duration of symptoms (p > 0.05). Conclusions: This cross-sectional study concluded that inactivated COVID-19 vaccination might increase the risk of Omicron infection, which should be a concern during COVID-19 vaccination and the treatment of variant infections in the future, and the receipt of at least one dose of non-inactivated COVID-19 vaccine was a protective factor against infection.


  • Open Access

    Effectiveness of Maternal Inactivated COVID-19 Vaccination against Omicron Infection in Infants during the First 12 Months of Life: A Test-Negative Case-Control Study

    by Jiayi Zhong, Wen Wang, Shuang Liu, Yifei Chen, Husheng Xiong, Xiang Meng, Dingmei Zhang, Yu Ma

    This study aims to evaluate the effectiveness of maternal inactivated COVID-19 vaccination before delivery for infants against Omicron infection in Guangzhou, China. A test-negative case-control design was conducted. This study selected infants born from 1 November 2021 to 23 November 2022 and tested for SARS-CoV-2 between 13 April 2022 and 30 November 2022 during outbreaks in Guangzhou. Multivariable logistic regression was performed to compare the maternal vaccination status of inactivated COVID-19 vaccines before delivery in cases and controls to estimate vaccine effectiveness (VE) for infants within 12 months. According to eligibility criteria, we finally selected 205 test-positive and 114 test-negative infants, as well as their mothers. The effectiveness of inactivated COVID-19 vaccines among fully vaccinated mothers was 48.4% (7.3% to 71.7%) for infants within 12 months, with the effectiveness of partial and booster vaccination showing no significant difference. Effectiveness for full vaccination presented a slight increase according to infants’ age at testing, with 49.6% (−12.3% to 78.4%) for 0–6 months and 59.9% (−0.6% to 84.4%) for over 6 months. A greater protective effect of two-dose vaccination was manifested in infants whose mother had received the second dose during the first trimester (65.9%, 95% CI: 7.7% to 87.9%) of pregnancy rather than preconception (43.5%, 95% CI: −8.7% to 71.1%). Moreover, VE could be improved to 77.1% (11.1% to 95.3%) when mothers received two doses both during pregnancy and 91.8% (41.1% to 99.6%) with receipt of a booster dose during pregnancy. Maternal vaccination with two doses of inactivated COVID-19 vaccines before delivery was moderately effective against Omicron infection in infants during the first 12 months of life. Full vaccination or a booster dose during pregnancy could confer better protection against Omicron for infants, although it might be overestimated due to the insufficient sample size in subgroups.